Zobrazeno 1 - 10
of 252
pro vyhledávání: '"Punnee, Pitisuttithum"'
Autor:
Viravarn Luvira, Punnee Pitisuttithum
Publikováno v:
Expert Review of Vaccines, Vol 23, Iss 1, Pp 283-293 (2024)
ABSTRACTIntroduction Inactivated vaccines were delivered to low- and middle-income countries during the early pandemics of COVID-19. Currently, more than 10 inactivated COVID-19 vaccines have been developed. Most inactivated vaccines contain an inact
Externí odkaz:
https://doaj.org/article/ec1b88a47f2d45e1b4ede051cadbf038
Autor:
Kombo F. N’guessan, Kawthar Machmach, Isabella Swafford, Margaret C. Costanzo, Lindsay Wieczorek, Dohoon Kim, Siriwat Akapirat, Victoria R. Polonis, Punnee Pitisuttithum, Sorachai Nitayaphan, Sanjay Gurunathan, Faruk Sinangil, Suwat Chariyalertsak, Julie A. Ake, Robert J. O’connell, Sandhya Vasan, Dominic Paquin-Proulx
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
The RV144 Thai phase III clinical trial’s canarypox–protein HIV vaccine regimen showed modest efficacy in reducing infection. We therefore sought to determine the effects of vaccine administration on innate cell activation and subsequent associat
Externí odkaz:
https://doaj.org/article/b63b37f19fa546188d5104a25d963234
Autor:
Suvimol Niyomnaitham, Anan Jongkaewwattana, Atibordee Meesing, Nawamin Pinpathomrat, Sira Nanthapisal, Nattiya Hirankarn, Sarawut Siwamogsatham, Suppachok Kirdlarp, Romanee Chaiwarith, Saranath Lawpoolsri, Supranee Phanthanawiboon, Arunee Thitithanyanont, Pokrath Hansasuta, Sansanee Chaiyaroj, Punnee Pitisuttithum
Publikováno v:
International Journal of Infectious Diseases, Vol 129, Iss , Pp 19-31 (2023)
Objectives: The study aimed to compare the immunogenicity and safety of fractional (half) third doses of heterologous COVID-19 vaccines (AZD1222 or BNT162b2) to full doses after the two-dose CoronaVac and when boosting after three different extended
Externí odkaz:
https://doaj.org/article/5c389074371f4ee3b9b88a004a527f2d
Autor:
Stefano Malvolti, Adam Soble, Paul Bloem, D Scott LaMontagne, Rakesh Aggarwal, Punnee Pitisuttithum, Helen Rees, Tania Cernuschi
Publikováno v:
Vaccines, Vol 12, Iss 1, p 4 (2023)
As of November 2023, 140 World Health Organization (WHO) member states had introduced human papillomavirus (HPV) vaccination in their routine immunization schedules. Despite a continuously increasing demand from countries across all income groups, su
Externí odkaz:
https://doaj.org/article/c9f677cb802d42b981c4dd798b172c69
Autor:
Trevor A. Crowell, Sorachai Nitayaphan, Narongrid Sirisopana, Tanyaporn Wansom, Suchai Kitsiripornchai, Leilani Francisco, Qun Li, Nicole Dear, Robert J. O’Connell, Punnee Pitisuttithum, Sandhya Vasan, for the RV348B Study Group
Publikováno v:
AIDS Research and Therapy, Vol 19, Iss 1, Pp 1-10 (2022)
Abstract Background Routine screening for HIV and other sexually transmitted infections (STIs) facilitates early diagnosis and treatment, thereby preventing morbidity and onward transmission. We estimated the prevalence of prior HIV/STI testing among
Externí odkaz:
https://doaj.org/article/f29f2e10848f46d9a689edbadcd2d6c7
Autor:
Augusta Horvath, Lisa Rogers, Georgios Pollakis, Olga Baranov, Nora Pieroth, Sarah Joseph, Mkunde Chachage, Asli Heitzer, Lucas Maganga, Frank Msafiri, Agricola Joachim, Edna Viegas, Leigh-Anne Eller, Hannah Kibuuka, Supachai Rerks-Ngarm, Punnee Pitisuttithum, Sorachai Nitayapan, Jittima Dhitavat, Nakorn Premsri, Sarah Fidler, Robin J. Shattock, Merlin Lee Robb, Jonathan Weber, Sheena McCormack, Patricia Jane Munseri, Eligius Lyamuya, Charlotta Nilsson, Arne Kroidl, Michael Hoelscher, Ralf Wagner, Christof Geldmacher, Kathrin Held
Publikováno v:
Frontiers in Immunology, Vol 13 (2023)
Immunogens and vaccination regimens can influence patterns of immune-epitope recognition, steering them towards or away from epitopes of potential viral vulnerability. HIV-1 envelope (Env)-specific antibodies targeting variable region 2 (V2) or 3 (V3
Externí odkaz:
https://doaj.org/article/df2a4d62eb904d36874c84f4d7ae26bd
Autor:
Suttiporn Prapaso, Viravarn Luvira, Saranath Lawpoolsri, Archin Songthap, Watcharapong Piyaphanee, Wiwat Chancharoenthana, Sant Muangnoicharoen, Punnee Pitisuttithum, Pornthep Chanthavanich
Publikováno v:
Tropical Diseases, Travel Medicine and Vaccines, Vol 7, Iss 1, Pp 1-10 (2021)
Abstract Background International travel is among the leading impactful factors of COVID-19 transmission; thus, adequate knowledge, good attitude and good preventive practices toward COVID-19 for international travelers are particularly essential for
Externí odkaz:
https://doaj.org/article/3217f7fb80ee4eb3a9ebc917f46b4986
Autor:
Punnee Pitisuttithum, Viravarn Luvira, Saranath Lawpoolsri, Sant Muangnoicharoen, Supitcha Kamolratanakul, Chaisith Sivakorn, Piengthong Narakorn, Somchaiya Surichan, Sumalee Prangpratanporn, Suttida Puksuriwong, Steven Lamola, Laina D. Mercer, Rama Raghunandan, Weina Sun, Yonghong Liu, Juan Manuel Carreño, Rami Scharf, Weerapong Phumratanaprapin, Fatima Amanat, Luc Gagnon, Ching-Lin Hsieh, Ruangchai Kaweepornpoj, Sarwat Khan, Manjari Lal, Stephen McCroskery, Jason McLellan, Ignacio Mena, Marcia Meseck, Benjaluck Phonrat, Yupa Sabmee, Ratsamikorn Singchareon, Stefan Slamanig, Nava Suthepakul, Johnstone Tcheou, Narumon Thantamnu, Sompone Theerasurakarn, Steven Tran, Thanakrit Vilasmongkolchai, Jessica A White, Nina Bhardwaj, Adolfo Garcia-Sastre, Peter Palese, Florian Krammer, Kittisak Poopipatpol, Ponthip Wirachwong, Richard Hjorth, Bruce L Innis
Publikováno v:
EClinicalMedicine, Vol 45, Iss , Pp 101323- (2022)
Summary: Background: Production of affordable coronavirus disease 2019 (COVID-19) vaccines in low- and middle-income countries is needed. NDV-HXP-S is an inactivated egg-based recombinant Newcastle disease virus vaccine expressing the spike (S) prote
Externí odkaz:
https://doaj.org/article/ffb4f5b1dc304f6186c8f2d2d34e14cf
Autor:
Melissa M. Lemke, Robert M. Theisen, Emily R. Bozich, Milla R. McLean, Christina Y. Lee, Ester Lopez, Supachai Rerks-Ngarm, Punnee Pitisuttithum, Sorachai Nitayaphan, Sven Kratochvil, Bruce D. Wines, P. Mark Hogarth, Stephen J. Kent, Amy W. Chung, Kelly B. Arnold
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Fc-mediated immune functions have been correlated with protection in the RV144 HIV vaccine trial and are important for immunity to a range of pathogens. IgG antibodies (Abs) that form complexes with Fc receptors (FcRs) on innate immune cells can acti
Externí odkaz:
https://doaj.org/article/35b3306aabcb40c09ff91806b53e7bb8
Autor:
Melissa M. Lemke, Milla R. McLean, Christina Y. Lee, Ester Lopez, Emily R. Bozich, Supachai Rerks-Ngarm, Punnee Pitisuttithum, Sorachai Nitayaphan, Sven Kratochvil, Bruce D. Wines, P. Mark Hogarth, Stephen J. Kent, Amy W. Chung, Kelly B. Arnold
Publikováno v:
Cell Reports Medicine, Vol 2, Iss 9, Pp 100386- (2021)
Summary: Immunoglobulin G (IgG) antibodies that activate Fc-mediated immune functions have been correlated with vaccine efficacy, but it is difficult to unravel the relative roles of multiple IgG and Fc receptor (FcR) features that have the capacity
Externí odkaz:
https://doaj.org/article/7ab01d1112034192a941db86e300e132